← Back to headlines
Edesa Biotech Reaffirms 2026 Timeline for Vitiligo Treatment Study
Edesa Biotech (EDSA) has reaffirmed its previously announced timeline for a clinical study on a vitiligo treatment, expected to commence in 2026.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
